Back to Journals » Drug Design, Development and Therapy » Call For Papers

SJR OA

CiteScore

Impact Factor

Drug Design, Development and Therapy

ISSN: 1177-8881

The following Article Collections/ Thematic Series are currently open for submissions:

Advances in design and development of ophthalmic drugs

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Advances in design and development of ophthalmic drugs", organized by Guest Advisors Dr. Georgios D. Panos in Drug Design, Development and Therapy.

This Article Collection will focus on the latest advances in drug design and development for the treatment of various ophthalmic diseases and conditions.

Ophthalmic diseases, including glaucoma, age-related macular degeneration, diabetic retinopathy, and dry eye disease, are a significant public health concern, affecting millions of people worldwide. Despite the increasing availability of some effective treatments, there is still an unmet need for safe and even more effective drugs that can treat these conditions.

This Article Collection will bring together leading researchers and clinicians in the field to present their latest research on the design and development of ophthalmic drugs. Topics that will be covered in this special issue include but are not limited to:

- New drug delivery systems for ophthalmic drugs
- Advances in small molecule drug design and development for ophthalmic conditions
- Nanotechnology-based approaches for ocular drug delivery
- Pharmacokinetics and pharmacodynamics of ophthalmic drugs
- Design and development of sustained-release ophthalmic drug delivery systems
- Gene Therapy and novel biological therapies for the treatment of ocular diseases

We welcome submissions of original research articles and review articles that address any aspect of drug design and development for ophthalmic diseases. All submitted manuscripts will undergo a rigorous peer-review process to ensure the highest quality of the published papers.

This Article Collection will provide a valuable resource for researchers, clinicians, and pharmaceutical companies working in the field of ophthalmic drug design and development and will further advance the understanding of the current state of the art in ophthalmic drug research and help pave the way for the development of safe and effective treatments for ophthalmic diseases.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submissions is 30 July 2024.

Please submit your manuscript on our website, quoting the promo code HMYJF to indicate that your submission is for consideration in this Article Collection.

View all papers in this article collection

Using Innovative Drug Delivery Systems to Improve the Efficacy and Applicability of Poorly Water-soluble Drugs

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Using Innovative Drug Delivery Systems to Improve the Efficacy and Applicability of Poorly Water-soluble Drugs" in Drug Design, Development and Therapy.

Failure of the conventional delivery of poorly water-soluble drugs could be attributed to their low solubility and hence their limited bioavailability that hinder their pharmacological applications.

The improvement of drug solubility is of a critical concern in boosting the dissolution rate and bioavailability. Recently, different techniques have been used to increase the solubility and bioavailability of poorly water-soluble drugs.

Using novel drug delivery systems and nano-based drug delivery systems can improve their solubility. Moreover, many of these systems act as drug reservoirs that also improve the drug permeability and stability. Accordingly, these delivery systems are important in improving the efficacy and applicability of poorly water-soluble drugs.

Topics that will be covered in this Article Collection include but are not limited to:

Novel drug delivery systems such as microemulsions, inclusion complexes, solid dispersions, cocrystals.
Nano-based drug delivery systems like nanosuspensions, liposomes, niosomes, proniosomes, transfersomes, etc.
Techniques to increase the solubility and bioavailability of poorly water-soluble drugs.

We welcome submissions of original research articles and review articles that address any aspect of design and development of innovative drug delivery systems to improve the efficacy and applicability of poorly water-soluble drugs. All submitted manuscripts will undergo a rigorous peer-review process to ensure the highest quality of the published papers.

The deadline for submissions is 13 May 2024. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, quoting the promo code KBOSG to indicate that your submission is for consideration in this Article Collection.

Guest advisors

Eman A. Mazyed, Department of pharmaceutical technology, Faculty of pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt

[email protected]

Kariman M. AbouElhassan, Department of Pharmaceutics, Faculty of Pharmacy, South Valley University, Qena, Egypt

[email protected]

View all papers in this article collection

Call For Papers

Editor-in-Chief: Prof. Dr. Frank Boeckler

To see where Drug Design, Development and Therapy is indexed online view the Journal Metrics.

What is the advantage to you of publishing in Drug Design, Development and Therapy?

It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
Although Drug Design, Development and Therapy receives a large number of papers, unlike many traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. Drug Design, Development and Therapy has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision.
Many authors have found that our peer reviewer’s comments substantially add to their final papers.

To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution an article publishing charge.

PubMed Central
Drug Design, Development and Therapy is indexed on PubMed and Medline (title abbreviation: Drug Des Devel Ther). All published papers in this journal are submitted to PubMed for indexing straight away.

Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee.
Click here to go through to the Favored Author signup page.

Yours sincerely
Prof. Dr. Frank Boeckler
Editor-in-Chief
Drug Design, Development and Therapy

Email: Editor-in-Chief